TY - JOUR
T1 - Filiform needle acupuncture for copd
T2 - A systematic review and meta-analysis
AU - Fernández-Jané, Carles
AU - Vilaró, Jordi
AU - Fei, Yutong
AU - Wang, Congcong
AU - Liu, Jianping
AU - Huang, Na
AU - Xia, Ruyu
AU - Tian, Xia
AU - Hu, Ruixue
AU - Yu, Mingkun
AU - Gómara-Toldrà, Natàlia
AU - Solà-Madurell, Mireia
AU - Sitjà-Rabert, Mercè
N1 - Funding Information:
During the preparation of this paper Carles Fernández was also given a grant from the Spanish Education Ministry .
Funding Information:
This work was supported by a grant from the Professional College of Physiotherapists of Catalonia .
Publisher Copyright:
© 2019 Elsevier Ltd
PY - 2019/12
Y1 - 2019/12
N2 - Background: This is the first part of a larger spectrum systematic review which aims to identify and evaluates the effectiveness of all different non-pharmacological acupuncture techniques used for COPD. In this first publication, we describe the results of filiform needle acupuncture Methods: Randomised controlled trials up to May 2019 were searched in 11 databases. Data extraction and risk of bias assessment was conducted in pairs independently. RevMan 5.3 was used for the meta-analysis. Results: 28 trials using filiform needle alone or in combination of other techniques were included. Compared with no acupuncture, no difference was seen for dyspnoea, but statistical benefits were found on quality of life (Std. MD: -0.62, 95%CI: -0.90, -0.34), exercise capacity (stable subgroup) (6MWT MD: 33.05 m, 95%CI: 19.11, 46.99) and lung function (FEV1% MD: 1.58, 95%CI: 0.51, 2.66). Compared with sham, statistical benefits were found on dyspnoea (Std. MD: -1.07, 95%CI: -1.58, -0.56), quality of life (Std. MD: -0.81, 95%CI: -1.12, -0.49), exercise capacity (6MWT MD: 76.68 m, 95% CI: 39.93, 113.43) and lung function (FEV1% MD: 5.40, 95%CI: 2.90, 7.91; FEV1/FVC MD: 6.64, 95%CI: 3.44, 9.83). Conclusions: Results show that filiform needle acupuncture might be beneficial for COPD, but due to the low quality of the studies this should be confirmed by future well-designed trials. Protocol registration: PROSPERO (identifier: CRD42014015074).
AB - Background: This is the first part of a larger spectrum systematic review which aims to identify and evaluates the effectiveness of all different non-pharmacological acupuncture techniques used for COPD. In this first publication, we describe the results of filiform needle acupuncture Methods: Randomised controlled trials up to May 2019 were searched in 11 databases. Data extraction and risk of bias assessment was conducted in pairs independently. RevMan 5.3 was used for the meta-analysis. Results: 28 trials using filiform needle alone or in combination of other techniques were included. Compared with no acupuncture, no difference was seen for dyspnoea, but statistical benefits were found on quality of life (Std. MD: -0.62, 95%CI: -0.90, -0.34), exercise capacity (stable subgroup) (6MWT MD: 33.05 m, 95%CI: 19.11, 46.99) and lung function (FEV1% MD: 1.58, 95%CI: 0.51, 2.66). Compared with sham, statistical benefits were found on dyspnoea (Std. MD: -1.07, 95%CI: -1.58, -0.56), quality of life (Std. MD: -0.81, 95%CI: -1.12, -0.49), exercise capacity (6MWT MD: 76.68 m, 95% CI: 39.93, 113.43) and lung function (FEV1% MD: 5.40, 95%CI: 2.90, 7.91; FEV1/FVC MD: 6.64, 95%CI: 3.44, 9.83). Conclusions: Results show that filiform needle acupuncture might be beneficial for COPD, but due to the low quality of the studies this should be confirmed by future well-designed trials. Protocol registration: PROSPERO (identifier: CRD42014015074).
KW - Acupuncture therapy
KW - COPD
KW - Dyspnea
KW - Meta-analysis
KW - Quality of life
KW - Systematic review
UR - http://www.scopus.com/inward/record.url?scp=85072304314&partnerID=8YFLogxK
U2 - 10.1016/j.ctim.2019.08.016
DO - 10.1016/j.ctim.2019.08.016
M3 - Article
C2 - 31780020
AN - SCOPUS:85072304314
SN - 0965-2299
VL - 47
JO - Complementary Therapies in Medicine
JF - Complementary Therapies in Medicine
M1 - 102182
ER -